KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bloomin' Brands (BLMN) Operating Income (2016 - 2025)

Bloomin' Brands (BLMN) has disclosed Operating Income for 15 consecutive years, with -$13.3 million as the latest value for Q4 2025.

  • Quarterly Operating Income fell 182.1% to -$13.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $37.2 million through Dec 2025, down 73.42% year-over-year, with the annual reading at $37.2 million for FY2025, 73.42% down from the prior year.
  • Operating Income hit -$13.3 million in Q4 2025 for Bloomin' Brands, up from -$36.4 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $124.6 million in Q2 2021 to a low of -$36.4 million in Q3 2025.
  • Historically, Operating Income has averaged $53.7 million across 5 years, with a median of $54.3 million in 2022.
  • Biggest five-year swings in Operating Income: surged 1184.36% in 2021 and later plummeted 521.43% in 2025.
  • Year by year, Operating Income stood at $78.5 million in 2021, then fell by 23.81% to $59.8 million in 2022, then decreased by 17.05% to $49.6 million in 2023, then tumbled by 67.34% to $16.2 million in 2024, then crashed by 182.1% to -$13.3 million in 2025.
  • Business Quant data shows Operating Income for BLMN at -$13.3 million in Q4 2025, -$36.4 million in Q3 2025, and $29.6 million in Q2 2025.